Allife Medical Science and Technology Co., Ltd

CRISPR-Cas Clinical Trial Update
Nov. 17, 2020

We have added 4 new CRISPR-Cas trials to our overview of current clinical trials involving gene editing.

Allife Medical Science and Technology Co., Ltd

Beta-Thalassemia, BT, (NCT03728322)
Sponsors:
Allife Medical Science and Technology Co., Ltd
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine